Enhanced Radiation Therapy Systems through Synergistic Combinations

The inventive concept integrates the patented alpha-emitter radiation therapy with distinct technologies, such as AI, IoT, blockchain, and new materials, to create more effective and personalized radiation therapy systems.

The original patent disclosed an implantable radiation source with combined alpha and non-alpha radiation. However, this invention had limitations in terms of radiation intensity adjustment, patient data management, and radiation absorption. The new inventive concept addresses these limitations by introducing synergistic combinations of alpha-emitter radiation therapy with AI, IoT, blockchain, and new materials.

The new inventive concept comprises four synergistic combinations: (1) AI-controlled beta radiation source, which adjusts radiation intensity based on real-time tumor imaging data; (2) IoT-enabled temperature sensing, which monitors tumor temperature and adjusts alpha-emitting radiation intensity; (3) blockchain-secured patient data management system, which tracks and verifies patient treatment history and radiation exposure; and (4) nanomaterial-enhanced coating, which enhances radiation absorption and reduces systemic alpha radiation.

The new inventive concept introduces non-obvious synergistic combinations of alpha-emitter radiation therapy with distinct technologies, which provide more effective and personalized radiation therapy systems. The inventive step lies in the integration of these technologies to create a more powerful system.

Alternative embodiments may include the use of other AI algorithms, IoT sensors, blockchain platforms, or nanomaterials. Variations may include different types of radiation therapy, such as brachytherapy or external beam radiation therapy.

The inventive concept has significant commercial potential in the radiation therapy market, particularly in the areas of cancer treatment and personalized medicine. The target industries include hospitals, cancer treatment centers, and medical device manufacturers.